Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study - 14/04/21

Kevin J. Severson, BS ^a, Helen J.L. Cumsky, MD ^a, Caitlin M. Brumfiel, MS ^a, Monica C. Janeczek, MD ^a, Brenda F. Ginos, MS ^b, Heidi E. Kosiorek, MS ^b, Jake Besch-Stokes, BS ^a, Meera H. Patel, BS ^a, William G. Rule, MD ^c, David J. DiCaudo, MD ^a, Allison C. Rosenthal, DO ^d, Mark R. Pittelkow, MD ^a, Aaron R. Mangold, MD ^{a, ⁎}

^a Department of Dermatology, Mayo Clinic Arizona, Phoenix, Arizona 

^b Department of Health Sciences Research, Mayo Clinic Arizona, Phoenix, Arizona 

^c Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona 

^d Division Hematology-Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, Arizona 

^∗Correspondence to: Aaron Mangold, MD, 13400 E Shea Blvd, Scottsdale, AZ 8525913400 E Shea BlvdScottsdaleAZ85259